Loading AMNPLST price...
Peers are the listed companies in the exchange's own industry group: Commodity Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales rose 7.3% from a year earlier to Rs 151 cr and profit rose 27.4% to Rs 9.5 cr.
- Debt to equity fell 2 years running (0.39 to 0.09).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 11 results, the share rose on 3 and fell on 8, and moved by 3% or more on 5.
Q1 FY27: results filed 14 Aug 2026. The share went from its close on 13 Aug 2026 to its close on 17 Aug 2026 -5.04%.
Of every Rs 100 of sales in FY26, Rs 90 went on running costs, Rs 1.0 on depreciation, Rs 1.0 on interest and Rs 2.2 on tax; Rs 6.4 was left as profit.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY24 | FY25 | FY26 |
|---|---|---|---|
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | - | 10.4% | 10.5% |
| Net marginProfit after everything, per Rs 100 of sales. | - | 6.2% | 6.4% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | 15.8% | 12.5% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | 26.6% | 23.2% | 17.5% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | 0.39x | 0.30x | 0.09x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | - | 6.6x | 10.0x |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 422 Cr of assets. Its owners funded 69% of that and borrowings 6%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs 66 Cr, spent Rs 1 Cr on plant and equipment, and cash rose by Rs 7 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| TATACHEM Tata Chemicals Limited | 15,184 cr | - | 0.7x | -8.9% | -3.2% | 0.36 | -13.0% | +14.4% | 1.84% |
| DEEPAKFERT Deepak Fertilizers and Petrochemicals Corporation Limited | 14,422 cr | 14.7x | 2.1x | 13.2% | 11.3% | 0.73 | 8.1% | +22.5% | 0.89% |
| GNFC Gujarat Narmada Valley Fertilizers and Chemicals Limited | 7,634 cr | 7.4x | 0.8x | 11.4% | 10.4% | 0.00 | 12.3% | +39.8% | 3.41% |
| GUJALKALI Gujarat Alkalies and Chemicals Limited | 4,043 cr | 60.9x | 0.8x | 1.3% | 1.6% | 0.11 | 1.5% | +12.7% | 2.88% |
| GHCL GHCL Limited | 3,486 cr | 6.8x | 1.0x | 14.6% | 16.9% | 0.02 | 17.1% | -2.7% | 3.29% |
| JGCHEM J.G.Chemicals Limited | 2,190 cr | 29.1x | 4.1x | 14.5% | 17.1% | 0.01 | 7.3% | +44.8% | 0.18% |
| IGPL IG Petrochemicals Limited | 1,596 cr | 19.5x | 1.2x | 6.1% | 3.1% | 0.27 | 3.9% | +31.4% | 1.93% |
| TIRUMALCHM Thirumalai Chemicals Limited | 1,428 cr | - | 0.9x | -9.7% | -3.3% | 1.34 | -8.3% | +21.5% | 0.00% |
| INDOBORAX Indo Borax & Chemicals Limited | 1,298 cr | 23.0x | 3.4x | 14.6% | 17.1% | 0.00 | 24.3% | +31.3% | 0.25% |
| ANDHRSUGAR The Andhra Sugars Limited | 1,038 cr | 9.9x | 0.6x | 6.2% | 6.5% | 0.00 | 4.4% | +4.5% | 1.07% |
| OCCLLTD OCCL Limited | 833 cr | 11.1x | 1.9x | 17.3% | 12.7% | 0.20 | 12.4% | +78.5% | 1.50% |
| SRHHYPOLTD Sree Rayalaseema Hi-Strength Hypo Limited | 814 cr | 8.8x | 0.8x | 9.3% | 11.6% | 0.00 | 13.2% | +17.0% | 0.63% |
| AMNPLST Amines & Plasticizers Limited | 774 cr | 20.1x | 2.6x | 13.2% | 17.5% | 0.09 | 6.6% | +7.3% | 0.36% |
| SADHNANIQ Sadhana Nitrochem Limited | 602 cr | - | 1.3x | - | -11.9% | 0.24 | - | -3.1% | 0.00% |
| PRIMO Primo Chemicals Limited | 573 cr | 36.4x | 1.4x | 3.9% | 7.1% | 0.32 | 2.9% | -1.2% | 0.00% |
| CHEMFAB Chemfab Alkalis Limited | 452 cr | - | 1.2x | -0.1% | 1.6% | 0.33 | -0.1% | -20.1% | 0.40% |
| MANORG Mangalam Organics Limited | 402 cr | 19.7x | 1.3x | 6.5% | 15.9% | 1.12 | 3.2% | +22.2% | 0.00% |
| LORDSCHLO Lords Chloro Alkali Limited | 371 cr | 10.9x | 1.5x | 13.6% | 12.6% | 0.67 | 8.3% | +6.1% | 0.00% |
| JOCIL Jocil Limited | 118 cr | 14.3x | 0.6x | 3.9% | 5.4% | 0.00 | 0.8% | -6.3% | 0.38% |
| TECILCHEM TECIL Chemicals and Hydro Power Limited | 16 cr | - | - | - | 7.4% | - | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 10.4% to 10.5% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.